Cutting Edge: CD99 Is a Novel Therapeutic Target for Control of T Cell-Mediated Central Nervous System Autoimmune Disease. Winger RC, Harp CT, Chiang M-Y, Sullivan DP, Watson RL, Weber EW, Podojil JR, Miller SD, Muller WA J Immunol. 2016 Jan 15. PMID: 26773145. Abstract CommentRecommendBookmarkWatch